Page 244 - SAHCS HIVMed Journal Vol 20 No 1 2019
P. 244
Page 7 of 7 Original Research
Health for providing access to the data used in this analysis. 10. Meintjes G, Black J, Conradie F, et al. Adult antiretroviral therapy guidelines 2014.
South Afr J HIV Med. 2014;15(4):121–143. https://doi.org/10.4102/hivmed.
This study was supported by the Research and Publications v15i4.330
Committee of the University of Venda, South Africa, and the 11. Corbeau P, Reynes J. Immune reconstitution under antiretroviral therapy: the new
South African Medical Research Council (RCDI) through challenge in HIV-1 infection. Blood. 2011;117(21):5582–5590. https://doi.org/
10.1182/blood-2010-12-322453
funding received from the South African National Treasury. 12. Zoufaly A, An Der Heiden M, Kollan C, et al. Clinical outcome of HIV infected
patients with discordant virological and immunological response to antiretroviral
therapy. J Infect Dis. 2011;203(3):364–371. https://doi.org/10.1093/jinfdis/jiq055
Competing interests 13. Billioux A, Nakigozi G, Newell K, et al. Durable suppression of HIV-1 after virologic
monitoring-based antiretroviral adherence counselling in Rakai, Uganda. PLoS
The authors declare that they have no financial or personal One [serial online]. 2015 [cited 2016 Mar 27];10(5). Available from: https://doi.
org/10.1371/journal.pone.0127235
relationship(s) that may have inappropriately influenced 14. Davey DJ, Abrahams Z, Feinberg M, et al. Factors associated with recent
them in writing this article. unsuppressed viral load in HIV-1-infected patients in care on first-line antiretroviral
therapy in South Africa. Int J STD AIDS. 2018;29(6):603–610. https://doi.org/
10.1177/ 0956462417748859
Authors’ contributions 15. Jobanputra K, Parker LA, Azih C, et al. Factors associated with virological failure
and suppression after enhanced adherence counselling, in children, adolescents
and adults on antiretroviral therapy for HIV in Swaziland. PLoS One. 2015;10(2):
A.E. was the project leader and also contributed to the study e0116144. https://doi.org/10.1371/journal.pone.0116144
design and analysis. P.O.B. and H.A. were responsible for the 16. Bello KJ, Mesner O, O’Bryan TA, et al. Factors associated with 10 years of
continuous viral load suppression on HAART. BMC Infect Dis [serial online]. 2016
conceptual contributions to the study design. [cited 2016 Dec 20];16(351). Available from: https://doi.org/10.1186/s12879-
016-1677-x
17. South African National Department of Health. National antiretroviral therapy
References guidelines. Pretoria: Jacana; 2004.
18. South African National Department of Health. South African standard treatment
1. Statistics South Africa. Mortality and causes of death in South Africa, 2013: Findings guidelines and essential medicines list – Hospital level for Adults. Pretoria:
South African National Department of Health; 2010.
from death notification [homepage on the Internet]. 2015 [cited 2016 Apr 26].
Available from: http://www.statssa.gov.za/publications/P03093/P030932013.pdf 19. Muzah BP, Takuva S, Maskew M, Delaney-Moretlwe S. Risk factors for discordant
2. Whiteside A, Cohen J, Strauss M. Reconciling the science and policy divide: The immune response among HIV-infected patients initiating antiretroviral therapy:
reality of scaling up antiretroviral therapy in South Africa. South Afr J HIV Med. A retrospective cohort study. South Afr J HIV Med. 2012;13(4):168–172. https://
doi.org/https://doi.org/10.4102/sajhivmed.v13i4.110
2015;16(1):355. https://doi.org/10.4102/sajhivmed.v16i1.355
3. UNAIDS. Prevention gap report [homepage on the Internet]. 2016 [cited 2016 20. Liddy C, Wiens M, Hogg W. Methods to achieve high interrater reliability in data
collection from primary care medical records. Ann Fam Med. 2011;9(1):57–62.
Apr 05]. Available from: http://www.unaids.org/sites/default/files/media_asset/ https://doi.org/10.1370/afm.1195
2016-prevention-gap-report_en.pdf
4. Wood E, Kerr T, Marshall BD, et al. Longitudinal community plasma HIV-1 RNA 21. Cameron D, Gerber A, Mbatha M, Mutyabule J, Swart H. Nurse Initiation and
maintenance of patients on antiretroviral therapy: Are nurses in primary care clinics
concentrations and incidence of HIV-1 among injecting drug users: prospective initiating ART after attending NIMART training? S Afr Med J. 2012;102: 98–100.
cohort study. BMJ. 2009;338(1649). https://doi.org/10.1136/bmj.b1649 https://doi.org/10.7196/SAMJ.5195
5. Montaner JSG, Lima VD, Barrios R, et al. Association of highly active antiretroviral 22. Johnson LF. Access to antiretroviral treatment in South Africa, 2004–2011. South
therapy coverage, population viral load, and yearly new HIV diagnoses in British Afr J HIV Med [serial online]. 2012 [cited 2016 Apr 19];13(1). Available from:
Columbia, Canada: A population-based study. Lancet. 2010;376 (9740):532–539. http://sajhivmed.org.za/index.php/hivmed/article/view/156/261
https://doi.org/10.1016/S0140-6736(10)60936-1
6. Rodger AJ, Cambiano V, Bruun T, et al. Sexual activity without condoms and risk of 23. Gichangi A, Wambua J, Gohole A, et al. Provision of oral HIV self-kits triples uptake
of HIV testing among male partners of antenatal care clients: results of a
HIV transmission in serodifferent couples when the HIV-positive partner is using randomised trial. Poster session presented at: 21st International AIDS conference
suppressive antiretroviral therapy. JAMA. 2016;316(2):171–181. https://doi.org/ of the International AIDS Society; 2016 Jul 18–22; Durban.
10.1001/jama.2016.5148 24. Boender TS, Sigaloff KCE, McMahon JH, et al. Long-term virological outcomes of
7. McMahon JH, Elliot JH, Bertagnolio S, Kubiak R, Jordan, JR. Viral Suppression after first-line antiretroviral therapy for HIV-1 in low- and middle-income countries:
12 months of antiretroviral therapy in low-and-medium-income countries: a A systematic review and meta-analysis. Clin Infect Dis. 2015;61(9):1453–1461.
systematic review. Bull World Health Org. 2013;91:377–385. https://doi.org/ https://doi.org/10.1093/cid/civ556
10.2471/BLT.12.112946 25. Mlangeni N, Senkubuge F. Antiretroviral therapy programme outcomes in
8. South African National Department of Health. South African standard treatment Tshwane district, South Africa: A 5-year retrospective study. S Afr Med J.
guidelines and essential medicines list – Hospital level for Adults. Pretoria: 2016;106(4): 365–368. https://doi.org/10.7196/SAMJ.2016.v106i4.9375
South African National Department of Health; 2012. 26. Boily M, Baggaley RF, Wang L, et al. Heterosexual risk of HIV-1 infection per sexual
9. Bartlett JG, Gallant JE, Pham PA. Medical Management of HIV infection. 16th ed. act: systemic review and meta-analysis of observational studies. Lancet Infect Dis.
Durham, NC: Knowledge Source Solutions; 2012. 2009;9:118–129. https://doi.org/10.1016/S1473-3099(09)70021-0
http://www.sajhivmed.org.za 237 Open Access